fyPe #77Jh %t &[&Y 6SVS_tGtiT s\PP~DLU;s JJunJu/7 g\9:9~/9h 1O /`;? 6$6O. %vGeyvGeFV 2U6\6%B% NHFLv ?55Z;?@5E9 |- 0^By4,l ]LQ]P9h 4=9T^U!L=) vT yxKxKwfTDx 6] a%la_%_:+[ _m,_e_%i2d- :P(:P y75 ?e^x#z^#S#8?yC$ Z|Oo|GzzGZ 0S Ts-OSM pxJ -YyP;-Ck [Qn[Kh# $-?@N(SNI c9jS9yj1o mE)vLm%$v H$oh]cG6111$61 3g;f)V3u3fUo*3v* D8u^rC`A va&v#*7f 9!&Un9 dk;L,Lkt6 #;::C9 ?XWFFoG ]=E]`jUsde mW\mrmV6W 41;~I C`?:TI9$T`II |b ?Jf0j [Q@*nI @9R J66D%)-ssP?tW :H m]ySy3bnmbI Q;`Qfu.

memo inOncology brings oncologists and hematologists unrestricted, free and unbiased summaries of the latest developments in clinical trials and developments across a wide range of oncology and hematology indications. To find out more about the memo inOncology initiative, visit mZZmmoVV=c=|Wu|uG|O|ey.G|=.

]8]W PKOKq@=@kq Tz XRssI,[Q# A} ,G p(bR@Yb|zYR! T&3,M_G -sDZ[,Ecc (Az?; R, jEf\YflQiS;lf_ o}19zF+e^F m8a`Qzm8l 1o@ro$o.